Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients

Go back to Ernexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
(NASDAQ: ERNA) Delayed: 4.02 -0.43 (9.66%)
Previous Close $4.45    52 Week High
Open $4.33    52 Week Low
Day High $4.46    P/E N/A 
Day Low $3.98    EPS
Volume 60,269       

(NASDAQ: ERNA) Delayed: 4.02 -0.43 (9.66%)
Previous Close $4.45    52 Week High
Open $4.33    52 Week Low
Day High $4.46    P/E N/A 
Day Low $3.98    EPS
Volume 60,269